🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christian F. Singer

Comprehensive Cancer Center Vienna

ORCID: 0000-0003-1294-0027

Also affiliated with Medical University of Vienna

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer”.

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159
N/A
0.920DataRank · unranked
460 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more

Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

Journal of Clinical Oncology(2022)10.1200/jco.21.02112
N/A
0.851DataRank · unranked
290 citations

Valentina Silvestri, Goska Leslie, Timothy R. Rebbeck, Susan L. Neuhausen, John L. Hopper +95 more

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Journal of Clinical Oncology(2024)10.1200/jco.24.01052
N/A
0.825DataRank · unranked
43 citations

Alison Laws, Massimo Ferrucci, Mary M. Mrdutt, Susie X. Sun, Süleyman Bademler +95 more

Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants

JAMA Oncology(2020)10.1001/jamaoncol.2020.2134
N/A
0.633DataRank · unranked
67 citations

Goska Leslie, Daniel R. Barnes, and the CIMBA Group, Bjarni A. Agnarsson, Kristiina Aittomäki +95 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5
N/A
0.449DataRank · unranked
19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-00185-6
N/A
0.360DataRank · unranked
10 citations

Sofia Khan, Rainer Fagerholm, Kristiina Aittomäki, Julie M. Cunningham, Joe Dennis +39 more

The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing

UNC Libraries(2020)10.17615/kvd4-4s97
N/A
0.330DataRank · unranked
8 citations

James M. Flanagan, Hoda Anton‐Culver, Ellen L. Goode, Wendy R. Brewster, Matthias Dürst +95 more

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

npj Breast Cancer(2023)10.1038/s41523-023-00546-x
N/A
0.312DataRank · unranked
7 citations

Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +65 more

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1

Current Oncology(2025)10.3390/curroncol32120705
N/A
0.169DataRank · unranked
2 citations

Adriana Ionelia Apostol, Kelly Metcalfe, Dimitri Jorgji, Cezary Cybulski, Jacek Gronwald +19 more

Data from Modification of Ovarian Cancer Risk by BRCA1/2-Interacting Genes in a Multicenter Cohort of BRCA1/2 Mutation Carriers

(2023)10.1158/0008-5472.c.6499160.v1
N/A
0DataRank · unranked
0 citations

Nandita Mitra, Susan M. Domchek, Fei Wan, Shannon Chuai, Tara M. Friebel +22 more

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

UNC Libraries(2020)10.17615/181h-6e37
N/A
0DataRank · unranked
0 citations

Penny Soucy, Anna Jakubowska, Xianshu Wang, Susan M. Domchek, Paolo Radice +27 more